{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:06:42Z","timestamp":1783980402273,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872247"],"award-info":[{"award-number":["81872247"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573853"],"award-info":[{"award-number":["82573853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,8,4]]},"DOI":"10.1038\/s41388-026-03853-2","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:57:15Z","timestamp":1781715435000},"page":"2945-2958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A feedback mechanism between E3 ligase RNF122 and HIF-1\u03b1 inhibits aggressive behavior in breast cancer"],"prefix":"10.1038","volume":"45","author":[{"given":"Quan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0617-5886","authenticated-orcid":false,"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9185-7225","authenticated-orcid":false,"given":"Yangfan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9385-7393","authenticated-orcid":false,"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"3853_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3853_CR2","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1172\/JCI95089","volume":"128","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhang B, Bao L, Jin L, Yang M, Peng Y, et al. ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis. J Clin Invest. 2018;128:1937\u201355.","journal-title":"J Clin Invest"},{"key":"3853_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.canlet.2020.11.045","volume":"502","author":"CE McAleese","year":"2021","unstructured":"McAleese CE, Choudhury C, Butcher NJ, Minchin RF. Hypoxia-mediated drug resistance in breast cancers. Cancer Lett. 2021;502:189\u201399.","journal-title":"Cancer Lett"},{"key":"3853_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145796","volume":"798","author":"M Rashid","year":"2021","unstructured":"Rashid M, Zadeh LR, Baradaran B, Molavi O, Ghesmati Z, Sabzichi M, et al. Up-down regulation of HIF-1alpha in cancer progression. Gene. 2021;798:145796.","journal-title":"Gene"},{"key":"3853_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1631\/jzus.B1400221","volume":"16","author":"ZJ Liu","year":"2015","unstructured":"Liu ZJ, Semenza GL, Zhang HF. Hypoxia-inducible factor 1 and breast cancer metastasis. J Zhejiang Univ Sci B. 2015;16:32\u201343.","journal-title":"J Zhejiang Univ Sci B"},{"key":"3853_CR6","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1172\/JCI137552","volume":"130","author":"EC de Heer","year":"2020","unstructured":"de Heer EC, Jalving M, Harris AL. HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer. J Clin Invest. 2020;130:5074\u201387.","journal-title":"J Clin Invest"},{"key":"3853_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"WG Kaelin Jr","year":"2008","unstructured":"Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30:393\u2013402.","journal-title":"Mol Cell"},{"key":"3853_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721\u201332.","journal-title":"Nat Rev Cancer"},{"key":"3853_CR9","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMra0910283","volume":"364","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364:656\u201365.","journal-title":"N Engl J Med"},{"key":"3853_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrc3621","volume":"13","author":"DC Bersten","year":"2013","unstructured":"Bersten DC, Sullivan AE, Peet DJ, Whitelaw ML. bHLH-PAS proteins in cancer. Nat Rev Cancer. 2013;13:827\u201341.","journal-title":"Nat Rev Cancer"},{"key":"3853_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","volume":"107","author":"AC Epstein","year":"2001","unstructured":"Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O\u2019Rourke J, Mole DR, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107:43\u201354.","journal-title":"Cell"},{"key":"3853_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1146\/annurev.biochem.74.082803.133142","volume":"74","author":"WG Kaelin","year":"2005","unstructured":"Kaelin WG. Proline hydroxylation and gene expression. Annu Rev Biochem. 2005;74:115\u201328.","journal-title":"Annu Rev Biochem"},{"key":"3853_CR13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.trecan.2019.08.005","volume":"5","author":"D Mennerich","year":"2019","unstructured":"Mennerich D, Kubaichuk K, Kietzmann T. DUBs, Hypoxia, and Cancer. Trends Cancer. 2019;5:632\u201353.","journal-title":"Trends Cancer"},{"key":"3853_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1146\/annurev-immunol-100819-121537","volume":"38","author":"SP Colgan","year":"2020","unstructured":"Colgan SP, Furuta GT, Taylor CT. Hypoxia and Innate Immunity: Keeping Up with the HIFsters. Annu Rev Immunol. 2020;38:341\u201363.","journal-title":"Annu Rev Immunol"},{"key":"3853_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ncb3330","volume":"18","author":"EL LaGory","year":"2016","unstructured":"LaGory EL, Giaccia AJ. The ever-expanding role of HIF in tumour and stromal biology. Nat Cell Biol. 2016;18:356\u201365.","journal-title":"Nat Cell Biol"},{"key":"3853_CR16","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/S1471-4914(02)02317-1","volume":"8","author":"GL Semenza","year":"2002","unstructured":"Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med. 2002;8:S62\u20137.","journal-title":"Trends Mol Med"},{"key":"3853_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","volume":"40","author":"AJ Majmundar","year":"2010","unstructured":"Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell. 2010;40:294\u2013309.","journal-title":"Mol Cell"},{"key":"3853_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-023-00848-6","volume":"23","author":"X Yuan","year":"2024","unstructured":"Yuan X, Ruan W, Bobrow B, Carmeliet P, Eltzschig HK. Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nat Rev Drug Discov. 2024;23:175\u2013200.","journal-title":"Nat Rev Drug Discov"},{"key":"3853_CR19","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1158\/1078-0432.CCR-10-1360","volume":"16","author":"X Lu","year":"2010","unstructured":"Lu X, Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res. 2010;16:5928\u201335.","journal-title":"Clin Cancer Res"},{"key":"3853_CR20","doi-asserted-by":"publisher","first-page":"6392","DOI":"10.1073\/pnas.0802047105","volume":"105","author":"C Sahlgren","year":"2008","unstructured":"Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA. 2008;105:6392\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3853_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature14492","volume":"522","author":"TR Cox","year":"2015","unstructured":"Cox TR, Rumney RMH, Schoof EM, Perryman L, Hoye AM, Agrawal A, et al. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature. 2015;522:106\u201310.","journal-title":"Nature"},{"key":"3853_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01947-w","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Zhang C, Zhao Y, Yue X, Wu H, Huang S, et al. Parkin targets HIF-1alpha for ubiquitination and degradation to inhibit breast tumor progression. Nat Commun. 2017;8:1823.","journal-title":"Nat Commun"},{"key":"3853_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.molcel.2007.01.001","volume":"25","author":"YV Liu","year":"2007","unstructured":"Liu YV, Baek JH, Zhang H, Diez R, Cole RN, Semenza GL. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol Cell. 2007;25:207\u201317.","journal-title":"Mol Cell"},{"key":"3853_CR24","doi-asserted-by":"publisher","first-page":"656","DOI":"10.4161\/cc.6.6.3981","volume":"6","author":"YV Liu","year":"2007","unstructured":"Liu YV, Semenza GL. RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization. Cell Cycle. 2007;6:656\u20139.","journal-title":"Cell Cycle"},{"key":"3853_CR25","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00018-008-7472-0","volume":"65","author":"E Benizri","year":"2008","unstructured":"Benizri E, Ginouves A, Berra E. The magic of the hypoxia-signaling cascade. Cell Mol Life Sci. 2008;65:1133\u201349.","journal-title":"Cell Mol Life Sci"},{"key":"3853_CR26","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1016\/j.celrep.2016.08.024","volume":"16","author":"JJ Thomas","year":"2016","unstructured":"Thomas JJ, Abed M, Heuberger J, Novak R, Zohar Y, Beltran Lopez AP, et al. RNF4-Dependent Oncogene Activation by Protein Stabilization. Cell Rep. 2016;16:3388\u2013400.","journal-title":"Cell Rep"},{"key":"3853_CR27","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1111\/jcmm.13694","volume":"22","author":"Z Liu","year":"2018","unstructured":"Liu Z, Zhang J, Xu J, Yang H, Li X, Hou Y, et al. RNF168 facilitates oestrogen receptor a transcription and drives breast cancer proliferation. J Cell Mol Med. 2018;22:4161\u201370.","journal-title":"J Cell Mol Med"},{"key":"3853_CR28","first-page":"239","volume":"38","author":"L Wang","year":"2006","unstructured":"Wang L, Shi TP, Wang L, Yu CF, Zeng LE, Wang J, et al. [Cloning, expression and subcellular localization of a novel human gene-RNF122]. Beijing Da Xue Xue Bao Yi Xue Ban. 2006;38:239\u201343.","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"3853_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-11-41","volume":"11","author":"Z Peng","year":"2010","unstructured":"Peng Z, Shi T, Ma D. RNF122: a novel ubiquitin ligase associated with calcium-modulating cyclophilin ligand. BMC Cell Biol. 2010;11:41.","journal-title":"BMC Cell Biol"},{"key":"3853_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1177\/1087057106286654","volume":"11","author":"L Wang","year":"2006","unstructured":"Wang L, Gao X, Gao P, Deng W, Yu P, Ma J, et al. Cell-based screening and validation of human novel genes associated with cell viability. J Biomol Screen. 2006;11:369\u201376.","journal-title":"J Biomol Screen"},{"key":"3853_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31764-9","volume":"13","author":"S Ma","year":"2022","unstructured":"Ma S, Zhao Y, Lee WC, Ong LT, Lee PL, Jiang Z, et al. Hypoxia induces HIF1alpha-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy. Nat Commun. 2022;13:4118.","journal-title":"Nat Commun"},{"key":"3853_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","volume":"148","author":"GL Semenza","year":"2012","unstructured":"Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148:399\u2013408.","journal-title":"Cell"},{"key":"3853_CR33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.gendis.2023.02.039","volume":"11","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Xing C, Deng Y, Ye C, Peng H. HIF-1alpha signaling: Essential roles in tumorigenesis and implications in targeted therapies. Genes Dis. 2024;11:234\u201351.","journal-title":"Genes Dis"},{"key":"3853_CR34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1146\/annurev-pharmtox-010818-021637","volume":"59","author":"GL Semenza","year":"2019","unstructured":"Semenza GL. Pharmacologic Targeting of Hypoxia-Inducible Factors. Annu Rev Pharmacol Toxicol. 2019;59:379\u2013403.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3853_CR35","doi-asserted-by":"publisher","first-page":"e1007259","DOI":"10.1371\/journal.ppat.1007259","volume":"14","author":"C Xu","year":"2018","unstructured":"Xu C, Liu X, Zha H, Fan S, Zhang D, Li S, et al. A pathogen-derived effector modulates host glucose metabolism by arginine GlcNAcylation of HIF-1alpha protein. PLoS Pathog. 2018;14:e1007259.","journal-title":"PLoS Pathog"},{"key":"3853_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009.","journal-title":"Nat Rev Dis Primers"},{"key":"3853_CR37","doi-asserted-by":"crossref","unstructured":"Zhang J, Zhang Q. VHL and hypoxia signaling: beyond HIF in Cancer. Biomedicines. 2018;6:35.","DOI":"10.3390\/biomedicines6010035"},{"key":"3853_CR38","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nature00767","volume":"417","author":"WC Hon","year":"2002","unstructured":"Hon WC, Wilson MI, Harlos K, Claridge TD, Schofield CJ, Pugh CW, et al. Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature. 2002;417:975\u20138.","journal-title":"Nature"},{"key":"3853_CR39","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1126\/science.1073440","volume":"296","author":"JH Min","year":"2002","unstructured":"Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr, Pavletich NP. Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science. 2002;296:1886\u20139.","journal-title":"Science"},{"key":"3853_CR40","doi-asserted-by":"publisher","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","volume":"23","author":"CJ Hu","year":"2003","unstructured":"Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol. 2003;23:9361\u201374.","journal-title":"Mol Cell Biol"},{"key":"3853_CR41","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nrclinonc.2010.171","volume":"7","author":"M Mego","year":"2010","unstructured":"Mego M, Mani SA, Cristofanilli M. Molecular mechanisms of metastasis in breast cancer-clinical applications. Nat Rev Clin Oncol. 2010;7:693\u2013701.","journal-title":"Nat Rev Clin Oncol"},{"key":"3853_CR42","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","volume":"21","author":"P Lee","year":"2020","unstructured":"Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21:268\u201383.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3853_CR43","doi-asserted-by":"crossref","unstructured":"Nolan E, Kang Y, Malanchi I. Mechanisms of Organ-Specific Metastasis of Breast Cancer. Cold Spring Harb Perspect Med. 2023;13:a041326.","DOI":"10.1101\/cshperspect.a041326"},{"key":"3853_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc3183","volume":"12","author":"B Keith","year":"2011","unstructured":"Keith B, Johnson RS, Simon MC. HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer. 2011;12:9\u201322.","journal-title":"Nat Rev Cancer"},{"key":"3853_CR45","doi-asserted-by":"crossref","unstructured":"Yang G, Shi R, Zhang Q. Hypoxia and oxygen-sensing signaling in gene regulation and cancer progression. Int J Mol Sci. 2020;21:8162.","DOI":"10.3390\/ijms21218162"},{"key":"3853_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02085-6","volume":"21","author":"Y Luo","year":"2021","unstructured":"Luo Y, Yin S, Lu J, Zhou S, Shao Y, Bao X, et al. Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment. Cancer Cell Int. 2021;21:386.","journal-title":"Cancer Cell Int"},{"key":"3853_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18:157.","journal-title":"Mol Cancer"},{"key":"3853_CR48","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1172\/JCI120855","volume":"129","author":"JC Chappell","year":"2019","unstructured":"Chappell JC, Payne LB, Rathmell WK. Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers. J Clin Invest. 2019;129:442\u201351.","journal-title":"J Clin Invest"},{"key":"3853_CR49","doi-asserted-by":"crossref","unstructured":"Foxler DE, Bridge KS, Foster JG, Grevitt P, Curry S, Shah KM, et al. A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia. EMBO Mol Med. 2018;10:e8304.","DOI":"10.15252\/emmm.201708304"},{"key":"3853_CR50","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/gutjnl-2019-319616","volume":"69","author":"S Ling","year":"2020","unstructured":"Ling S, Shan Q, Zhan Q, Ye Q, Liu P, Xu S, et al. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1alpha\/USP22 positive feedback loop upon TP53 inactivation. Gut. 2020;69:1322\u201334.","journal-title":"Gut"},{"key":"3853_CR51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aaf4405","volume":"352","author":"EB Rankin","year":"2016","unstructured":"Rankin EB, Giaccia AJ. Hypoxic control of metastasis. Science. 2016;352:175\u201380.","journal-title":"Science"},{"key":"3853_CR52","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/15548627.2015.1042195","volume":"11","author":"VP Tan","year":"2015","unstructured":"Tan VP, Miyamoto S. HK2\/hexokinase-II integrates glycolysis and autophagy to confer cellular protection. Autophagy. 2015;11:963\u20134.","journal-title":"Autophagy"},{"key":"3853_CR53","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrd.2015.17","volume":"15","author":"N Ferrara","year":"2016","unstructured":"Ferrara N, Adamis AP. Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discov. 2016;15:385\u2013403.","journal-title":"Nat Rev Drug Discov"},{"key":"3853_CR54","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.1128\/MCB.00773-08","volume":"28","author":"MY Koh","year":"2008","unstructured":"Koh MY, Darnay BG, Powis G. Hypoxia-associated factor, a novel E3-ubiquitin ligase, binds and ubiquitinates hypoxia-inducible factor 1alpha, leading to its oxygen-independent degradation. Mol Cell Biol. 2008;28:7081\u201395.","journal-title":"Mol Cell Biol"},{"key":"3853_CR55","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature11207","volume":"487","author":"M Montagner","year":"2012","unstructured":"Montagner M, Enzo E, Forcato M, Zanconato F, Parenti A, Rampazzo E, et al. SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature. 2012;487:380\u20134.","journal-title":"Nature"},{"key":"3853_CR56","doi-asserted-by":"publisher","first-page":"9581","DOI":"10.1073\/pnas.1604277113","volume":"113","author":"W Wang","year":"2016","unstructured":"Wang W, Jiang M, Liu S, Zhang S, Liu W, Ma Y, et al. RNF122 suppresses antiviral type I interferon production by targeting RIG-I CARDs to mediate RIG-I degradation. Proc Natl Acad Sci USA. 2016;113:9581\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3853_CR57","doi-asserted-by":"crossref","unstructured":"Sun R, Guo Y, Li X, Li R, Shi J, Tan Z, et al. PRRSV Non-Structural Proteins Orchestrate Porcine E3 Ubiquitin Ligase RNF122 to Promote PRRSV Proliferation. Viruses. 2022;14:424.","DOI":"10.3390\/v14020424"},{"key":"3853_CR58","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek KN, Komander D. Ubiquitin modifications. Cell Res. 2016;26:399\u2013422.","journal-title":"Cell Res"},{"key":"3853_CR59","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.celrep.2017.10.020","volume":"21","author":"C Zhao","year":"2017","unstructured":"Zhao C, Jia M, Song H, Yu Z, Wang W, Li Q, et al. The E3 Ubiquitin Ligase TRIM40 Attenuates Antiviral Immune Responses by Targeting MDA5 and RIG-I. Cell Rep. 2017;21:1613\u201323.","journal-title":"Cell Rep"},{"key":"3853_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22987-3","volume":"12","author":"D Wang","year":"2021","unstructured":"Wang D, Zhang Y, Xu X, Wu J, Peng Y, Li J, et al. YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3. Nat Commun. 2021;12:2674.","journal-title":"Nat Commun"},{"key":"3853_CR61","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1101\/gad.1003602","volume":"16","author":"WG Kaelin Jr","year":"2002","unstructured":"Kaelin WG Jr. How oxygen makes its presence felt. Genes Dev. 2002;16:1441\u20135.","journal-title":"Genes Dev"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03853-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03853-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03853-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:02:00Z","timestamp":1783980120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03853-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":61,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2026,8,4]]}},"alternative-id":["3853"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03853-2","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The animal study was approved by the Institutional Animal Care and Use Committee of Dalian Medical University (approval no. AEE21015). The use of human tumor tissues was approved by the Institutional Review Board of Dalian Medical University (approval no. PJ-KS-KY-2022-208). Written informed consent was obtained from all patients or their guardians prior to participation in the study. This manuscript does not contain any identifiable images of human participants; therefore, no additional consent for publication of images was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}